Drug Report History

Return to report

Below you will find the report version history. When a report is updated, a new version of the report is created. The report history allows you to see the changes between versions. You can select two versions of the report to compare. The fields that were changed between versions will be highlighted in yellow.

The translation of reports creates two separate versions which is why some reports may not seem to have any differences. In this case, only the language field below will be highlighted in yellow.

Version v19-FR Version v7-FR
Language French French
Date Updated 2019-05-31 2018-04-23
Drug Identification Number 02446022 02446022
Brand name DILTIAZEM CD DILTIAZEM CD
Common or Proper name DILTIAZEM CD DILTIAZEM CD
Company Name SIVEM PHARMACEUTICALS ULC SIVEM PHARMACEUTICALS ULC
Ingredients DILTIAZEM HYDROCHLORIDE DILTIAZEM HYDROCHLORIDE
Strength(s) 300MG 300MG
Dosage form(s) CAPSULE (EXTENDED RELEASE) CAPSULE (EXTENDED RELEASE)
Route of administration ORAL ORAL
Packaging size 100 100
ATC code C08DB C08DB
ATC description SELECTIVE CALC.CHANNEL BLOCK. W/DIRECT CARDIAC EFF SELECTIVE CALC.CHANNEL BLOCK. W/DIRECT CARDIAC EFF
Reason for shortage Requirements related to complying with good manufacturing practices. Requirements related to complying with good manufacturing practices.
Anticipated start date 2018-04-10 2018-04-10
Actual start date 2018-04-10 2018-04-10
Estimated end date 2019-05-31 2018-05-18
Actual end date 2019-05-31
Shortage status Actual shortage Actual shortage
Tier 3 Status No No
Company comments UNAVAILABLE
Health Canada comments